24Sep 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax

A systematic review and meta-analysis involving 23 studies and 6,879 patients across 16 countries has shed light on the effectiveness of primaquine in preventing Plasmodium vivax recurrence. The research found that a high total dose of primaquine (7 mg/kg) significantly reduced P vivax recurrences compared to no treatment or a low total dose (3.5 mg/kg). The risk of recurrence at day 180 was 8.1% with high-dose primaquine, 19.3% with low-dose, and 51% without treatment. The study suggests that increasing primaquine dosage can cut recurrences by over 50% in most endemic areas, with manageable gastrointestinal side effects.

  • #general medicine

Like

Save

Share